Clinical trial
Special Drug Use Investigation of EYLEA for CRVO
NCT02040220 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Investigation of EYLEA for CRVO
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 24, 2014
- Completion date
- November 9, 2018
- Enrollment
- 385 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.